TABLE 3.
Model 1 | Model 2 | Model 3 | |||||
|
|
|
|||||
P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | ||
CVD | 1 | Reference | Reference | Reference | |||
2 | >0.05 | 1.04 (0.42∼2.62) | >0.05 | 0.90 (0.36∼2.27) | >0.05 | 0.78 (0.31∼1.98) | |
3 | <0.01 | 2.00 (1.36∼2.93) | <0.01 | 1.84 (1.25∼2.70) | <0.01* | 1.43 (0.97∼2.10) | |
4 | <0.01 | 4.17 (2.48∼7.00) | <0.01 | 3.17 (1.87∼5.39) | <0.01* | 2.38 (1.40∼4.05) | |
All-cause mortality | 1 | Reference | Reference | Reference | |||
2 | >0.05 | 1.63 (0.70∼3.81) | >0.05 | 1.66 (0.71∼3.89) | >0.05 | 1.59 (0.68∼3.74) | |
3 | <0.01 | 1.86 (1.31∼2.66) | <0.01 | 1.86 (1.30∼2.66) | <0.01* | 1.73 (1.20∼2.48) | |
4 | <0.01 | 2.32 (1.36∼3.94) | <0.01 | 2.25 (1.30∼3.88) | <0.01* | 2.08 (1.20∼3.59) | |
CI | 1 | Reference | Reference | Reference | |||
2 | >0.05 | 0.99 (0.30∼3.22) | >0.05 | 0.87 (0.27∼2.88) | >0.05 | 0.78 (0.31∼1.98) | |
3 | <0.01 | 2.19 (1.37∼3.49) | <0.01 | 1.99 (1.25∼3.16) | >0.05 | 1.50 (0.94∼2.39) | |
4 | <0.01 | 4.50 (2.42∼8.37) | <0.01 | 3.35 (1.78∼6.31) | <0.01* | 2.47 (1.31∼4.67) | |
MI | 1 | Reference | Reference | Reference | |||
2 | >0.05 | 0.71 (0.09∼5.44) | >0.05 | 0.60 (0.08∼4.62) | >0.05 | 0.50 (0.07∼3.91) | |
3 | <0.01 | 1.76 (0.83∼3.75) | >0.05 | 1.55 (0.73∼3.32) | >0.05 | 1.36 (0.63∼2.94) | |
4 | <0.01 | 1.99 (0.56∼7.11) | >0.05 | 1.56 (0.43∼5.65) | >0.05 | 1.25 (0.34∼4.58) |
Model 1 corrected for age and gender. Model 2 further corrected BMI, total cholesterol (TC), and high-density lipoprotein (HDL) based on Model 1. Model 3 further corrected smoking, drinking alcohol, hypertension, diabetes, and taking hypotensive drugs based on Model 2. HR, hazard ratios; 95% CI, 95% confidence interval; CVD, cardiovascular disease; CI, cerebral ischemia; MI, myocardial infarction. *Statistically significant (P < 0.05).